Organization
CENTER FOR MOLECULAR CANCER DIAGNOSTICS, INC
According to 2025 Medicare claims, CENTER FOR MOLECULAR CANCER DIAGNOSTICS, INC (NPI: 1316378789) practices clinical laboratory (billing independently) in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is CENTER FOR MOLECULAR CANCER DIAGNOSTICS, INC (NPI: 1316378789; TIN: 452172398) and primary practice location at 44060-4806.
The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,785 traditional Medicare patients, billed 97,117 HCPCS/CPT codes, and received $1,523,322 in Medicare payments. The top billing code was 87640 (Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $39,683 to $1,523,322. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.